Private Market View

Epitel

Salt Lake City, UT · Founded 2007 · Privately Held (backing)

Last price · $/share
—
Implied valuation
$83.0M
Total raised
$33.9M
Last round
—

Key facts

  • Epitel’s last known valuation is $83.0M (Sep 2025).
  • It has raised $33.9M; the latest was Later Stage VC ($21.0M) in Sep 2025.
  • Notable investors include MedTech Innovator, National Institutes of Health, Genoa Ventures, OSF Ventures, Angel Physicians Fund — 21 tracked in total.
  • 1 investment vehicle was formed to buy Epitel shares in the last 12 months, reporting $1.2M sold to 23 investors, per SEC Form D filings.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 21 names
  • ·Watchlist + deal alerts for Epitel
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Epitel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 1 investment vehicle were formed to buy Epitel shares, reporting $1.2M sold to 23 investors. Most recent filing Jun 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 1 vehicle →
Companies with the most vehicle activity →

About Epitel

Developer of a brain health monitoring device designed to detect abnormal brain activities accurately. The company's device leverages a cloud-based wearable sensor system and innovative artificial intelligence (AI) technologies to provide accessible, affordable and reliable electrographic seizure detection, enabling physicians, caregivers and patients suffering from neurological disorders to access brain health insights to improve the quality of life and care.

Sector
Healthcare
HQ
Salt Lake City, UT, United States
Founded
2007
Employees
48
Ownership
Privately Held (backing)
PA Mark — not yet priced

Epitel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Epitel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Epitel in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.